Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication.
He
M L
ML
Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong SAR, China. mlhe@cuhk.edu.hk
Zheng
B J
BJ
Chen
Y
Y
Wong
K L
KL
Huang
J D
JD
Lin
M C
MC
Yuen
K Y
KY
Sung
J J Y
JJ
Kung
H F
HF
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002478:Cells, Cultured; D007668:Kidney / Q000166:cytology; D008253:Macaca mulatta; D012313:RNA / Q000096:biosynthesis* / Q000235:genetics; D034741:RNA, Small Interfering / Q000096:biosynthesis* / Q000235:genetics / Q000494:pharmacology*; D045473:Severe acute respiratory syndrome-related coronavirus / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D034741:RNA, Small Interfering; C039919:RNA, recombinant; D012313:RNA